Status:
UNKNOWN
Effects of a Novel Supplement on Sleep, Metabolism, Body Composition and Performance
Lead Sponsor:
Bettery S.A.
Conditions:
Sleep Hygiene
Sleep Disturbance
Eligibility:
All Genders
35-55 years
Phase:
NA
Brief Summary
This study aimed to investigate the effects of a novel dietary supplement, consisting of melatonin and magnesium in a pod (coffee machine capsule) format, on sleep quality, stress, mood, sleepiness, b...
Detailed Description
A randomized, double-blind, crossover design will be used to investigate the efficacy of a novel developed melatonin and magnesium supplement in pod (coffee machine capsule) format on sleep patterns a...
Eligibility Criteria
Inclusion
- Pittsburgh Sleep Quality Index \>5 as an indicator of sleep disturbance.
Exclusion
- Taking medication which interferes with sleep;
- Shift workers;
- Workers who may experience jet lag (e.g. flight personnel).
Key Trial Info
Start Date :
November 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2022
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT05236504
Start Date
November 28 2021
End Date
July 30 2022
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bettery, S.A.
Porto Salvo, Oeiras, Portugal, 2740-267